Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
alteplase (Activase) (1 trial)
tenecteplase (tnkase) (1 trial)
Infarction, Middle Cerebral Artery (Phase 2)
Nervous System Diseases (Phase 2)
Trials (1 total)
Trial APIs (2 total)